These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3422175)

  • 21. All-trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients.
    Visani G; Zauli G; Tosi P; Ottaviani E; Gibellini D; Manfroi S; Celeghini C; Pagliarini C; Bassini A; Tura S
    Leukemia; 1994 Dec; 8(12):2183-7. PubMed ID: 7528859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long term follow-up of remission patients in adult acute leukemia.
    Gerecke D; Kress M; Hirschmann WD
    Klin Wochenschr; 1983 Oct; 61(19):963-7. PubMed ID: 6580502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative analysis of 3 therapeutic regimens based on the combination of an anthracycline and cytosine arabinoside for remission induction in myeloblastic leukemia].
    Sanz MA; Lorenzo JI; Sanz GF; Martín Aragonés G; Rafecas FJ; Martínez JA; Gomis F
    Sangre (Barc); 1988 Dec; 33(6):497-504. PubMed ID: 3247626
    [No Abstract]   [Full Text] [Related]  

  • 24. Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia.
    Arellano M; Pakkala S; Langston A; Tighiouart M; Pan L; Chen Z; Heffner LT; Lonial S; Winton E; Khoury HJ
    Cancer; 2012 Nov; 118(21):5278-82. PubMed ID: 22517268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TAD-induction therapy for 175 adults with acute myeloid leukemia, followed by consolidation and maintenance therapy. The joint study of Ulm and Tübingen.
    Link H; Kurrle E; Frauer HM; Heil G; Heimpel H; Waller HD; Ostendorf P; Wilms K; Hoelzer D
    Onkologie; 1986 Jun; 9(3):135-8. PubMed ID: 3528958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aggressive chemotherapy for acute leukemia relapsed after bone marrow transplantation: a second chance?
    Sica S; Di Mario A; Pagano L; Etuk B; Salutari P; Leone G
    Acta Haematol; 1992; 87(4):173-5. PubMed ID: 1519431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistence of peripheral blood and bone marrow blasts during remission induction in adult acute lymphoblastic leukemia confers a poor prognosis depending on treatment intensity.
    Cortes J; Fayad L; O'Brien S; Keating M; Kantarjian H
    Clin Cancer Res; 1999 Sep; 5(9):2491-7. PubMed ID: 10499624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A characteristic pattern of leukemic cell differentiation without cytoreduction during remission induction in acute promyelocytic leukemia.
    Kantarjian HM; Keating MJ; McCredie KB; Beran M; Walters R; Dalton WT; Hittleman W; Freireich EJ
    J Clin Oncol; 1985 Jun; 3(6):793-8. PubMed ID: 3859586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy of advanced acute myeloblastic leukemia with cytarabine and interleukin 2.
    Butturini A; Bonilauri E; Izzi G; Croci G; Franchi F; Santucci MA; Tondelli MT; Castriota Scanderbeg A
    Leuk Res; 1991; 15(8):759-63. PubMed ID: 1910127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of myeloperoxidase containing blast cells in acute myelogenous leukaemia.
    Advani SH; Hegde UP; Iyer RS; Gopal R; Saikia TK; Pai SK; Nair CN; Kurkure PA; Pai VR; Nadkarni KS
    Indian J Med Res; 1993 Feb; 98():8-14. PubMed ID: 8388366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High rate of long-term survival in adult acute leukemia following ten-day chemotherapy (OAP) induction. Maintenance with chemotherapy or chemotherapy plus BCG vaccine.
    Hewlett JS; Chen T; Balcerzak SP; Gutterman JU; Costanzi JJ; Amare M
    Arch Intern Med; 1985 Jun; 145(6):1006-12. PubMed ID: 3890786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation.
    Pfrepper C; Klink A; Behre G; Schenk T; Franke GN; Jentzsch M; Schwind S; Al-Ali HK; Hochhaus A; Niederwieser D; Sayer HG
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):317-24. PubMed ID: 26424692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of various types of acute leukemia in adult. An analysis of 98 cases. The Leukemia Cooperation Group of Beijing City].
    Zhonghua Nei Ke Za Zhi; 1992 Mar; 31(3):139-42, 187. PubMed ID: 1395923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensive treatment of acute leukemia in adults 70 years of age and older.
    Walters RS; Kantarjian HM; Keating MJ; Estey EH; McCredie KB; Freireich EJ
    Cancer; 1987 Jul; 60(2):149-55. PubMed ID: 3474052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OAP combination in the treatment of elderly leukaemic patients with preexisting severe internal disease.
    Marra R; Pagano L; Liene DR; Storti S; Girasoli M; Leone G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):187-91. PubMed ID: 2475396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission.
    Dahl GV; Kalwinsky DK; Mirro J; Look AT; Pui CH; Murphy SB; Mason C; Ruggiero M; Schell M; Johnson FL
    J Clin Oncol; 1990 Feb; 8(2):295-303. PubMed ID: 2299372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low platelet count reduces subsequent complete remission rate despite marrow with <5% blasts after AML induction therapy.
    Chen X; Newell LF; Xie H; Walter RB; Pagel JM; Sandhu VK; Becker PS; Hendrie PC; Abkowitz JL; Appelbaum FR; Estey EH
    Leukemia; 2015 Aug; 29(8):1779-80. PubMed ID: 25650090
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of clinical remission and survival between CLAG and FLAG induction chemotherapy in patients with refractory or relapsed acute myeloid leukemia: a prospective cohort study.
    Bao Y; Zhao J; Li ZZ
    Clin Transl Oncol; 2018 Jul; 20(7):870-880. PubMed ID: 29181696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current therapeutic strategies in the management of acute myeloid leukemia].
    Fiegl M; Hiddemann W; Braess J
    Med Klin (Munich); 2007 Apr; 102(4):309-16. PubMed ID: 17426934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Initial response to therapy as an important prognostic factor in acute lymphoblastic leukemia in childhood. COALL study group].
    Janka-Schaub GE; Stührk H; Kortüm B; Graubner U; Jürgens H; Spaar HJ; Schöck V; Dohrn B; Bahr R; Winkler K
    Klin Padiatr; 1991; 203(4):231-5. PubMed ID: 1942930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.